Here's the live share price of Medplus Health Services along with daily highs, lows, percentage changes and volume trends, and, all financial information.
Over the last 5 years, the share price of Medplus Health Services has declined 5.59% CAGR. Over the past year, the corresponding return has been 18.36%.
Medplus Health Services’s current P/E of 56.50x helps give context to how the market is valuing the stock based on recent earnings and growth expectations. Check out if this stock is part of our Highest YOY Quarterly profit growth Screener.
Name | 1W(%) | 1M(%) | 3M(%) | 6M(%) | 1Y(%) | 3Y(%) | 5Y(%) |
---|---|---|---|---|---|---|---|
Medplus Health Services | 0.96 | 3.07 | -5.34 | 19.26 | 18.36 | 5.26 | -5.59 |
Sun Pharmaceutical Industries | 0.97 | -0.73 | -4.56 | -3.95 | -13.67 | 21.98 | 26.56 |
Divi's Laboratories | 0.07 | 0.88 | -10.55 | 6.14 | 9.71 | 17.82 | 13.69 |
Cipla | 1.32 | 3.49 | 4.77 | 8.25 | -5.03 | 13.91 | 16.87 |
Torrent Pharmaceuticals | -0.56 | -1.88 | 9.19 | 14.98 | 2.90 | 33.17 | 20.55 |
Dr. Reddy's Laboratories | 3.77 | 7.85 | -3.43 | 19.10 | -1.52 | 15.58 | 8.56 |
Mankind Pharma | 1.25 | 6.28 | 8.24 | 19.09 | 6.23 | 21.96 | 12.65 |
Zydus Lifesciences | 3.03 | 9.28 | 6.77 | 17.53 | -6.72 | 40.52 | 23.17 |
Lupin | 5.05 | 5.10 | 1.03 | 3.96 | -9.07 | 44.90 | 16.11 |
Abbott India | -0.30 | -3.89 | -1.24 | 4.23 | 4.63 | 19.70 | 13.47 |
Alkem Laboratories | 1.96 | 5.64 | 12.31 | 14.54 | -14.27 | 19.30 | 13.34 |
Aurobindo Pharma | 4.78 | 3.43 | -5.26 | -1.14 | -29.86 | 25.70 | 6.59 |
Glenmark Pharmaceuticals | 3.46 | 3.29 | 29.73 | 49.52 | 21.55 | 75.97 | 34.52 |
Biocon | 0.26 | 2.78 | 3.50 | 12.23 | -3.13 | 6.33 | -3.24 |
Laurus Labs | 1.70 | 7.84 | 34.48 | 53.36 | 76.74 | 17.90 | 27.44 |
GlaxoSmithKline Pharmaceuticals | 0.17 | 7.18 | -16.38 | 3.45 | -3.04 | 24.98 | 9.94 |
Anthem Biosciences | 0.28 | 11.92 | 13.93 | 13.93 | 13.93 | 4.44 | 2.64 |
Cohance Lifesciences | 5.60 | 2.61 | -3.08 | -15.81 | -17.91 | 26.94 | 21.87 |
Ipca Laboratories | -1.62 | -4.55 | -5.03 | -0.24 | -9.78 | 14.50 | 4.09 |
Gland Pharma | 6.68 | 4.84 | 21.20 | 28.02 | 6.91 | -5.10 | 2.10 |
Over the last one year, Medplus Health Services has gained 18.36% compared to peers like Sun Pharmaceutical Industries (-13.67%), Divi's Laboratories (9.71%), Cipla (-5.03%). From a 5 year perspective, Medplus Health Services has underperformed peers relative to Sun Pharmaceutical Industries (26.56%) and Divi's Laboratories (13.69%).
Day | SMA | EMA |
---|---|---|
5 | 834.95 | 833.07 |
10 | 836.51 | 834.7 |
20 | 831.58 | 839.19 |
50 | 863.2 | 852.35 |
100 | 868.38 | 847.24 |
200 | 820.75 | 819.37 |
In the latest quarter, Medplus Health Services saw a drop in promoter holding to 40.32%, while DII stake decreased to 26.03%, FII holding rose to 16.43%, and public shareholding moved down to 17.18% compared to the previous quarter — reflecting a shift in investor sentiment across categories.
Fund Name | No. Of Shares | % of AUM | Amount Invested(in ₹ crore) |
---|---|---|---|
Nippon India Pharma Fund | 36,27,277 | 3.86 | 337.54 |
Kotak Small Cap Fund - Regular Plan | 35,78,425 | 1.86 | 332.99 |
Nippon India Multi Cap Fund | 25,27,912 | 0.51 | 235.23 |
Franklin India Smaller Companies Fund | 24,32,539 | 1.64 | 226.36 |
Nippon India Focused Equity Fund | 20,98,553 | 2.27 | 195.28 |
SBI Long Term Equity Fund | 17,23,010 | 0.53 | 160.33 |
Invesco India Large & Mid Cap Fund | 11,54,182 | 1.34 | 107.4 |
Franklin India Flexi Cap Fund | 11,32,626 | 0.56 | 105.4 |
Invesco India Contra Fund | 10,94,617 | 0.53 | 101.86 |
Invesco India Mid Cap Fund | 10,50,416 | 1.25 | 97.75 |
Date Time | Announcement |
---|---|
Sep 10, 2025, 11:49 PM IST | Medplus Health Serv - Update Under Regulation 30 Read With Para A Part A Of Schedule III Of SEBI (Listing Obligations And Dis |
Sep 09, 2025, 11:57 PM IST | Medplus Health Serv - Update Under Regulation 30 Read With Para A Part A Of Schedule III Of SEBI (Listing Obligations And Dis |
Sep 05, 2025, 11:56 PM IST | Medplus Health Serv - Update Under Regulation 30 Read With Para A Part A Of Schedule III Of SEBI (Listing Obligations And Dis |
Sep 05, 2025, 12:08 AM IST | Medplus Health Serv - Update Under Regulation 30 Read With Para A Part A Of Schedule III Of SEBI (Listing Obligations And Dis |
Aug 27, 2025, 12:37 AM IST | Medplus Health Serv - Update Under Regulation 30 Read With Para A Part A Of Schedule III Of SEBI (Listing Obligations And Dis |
Medplus Health Services Ltd. is a Public Limited Listed company incorporated on 30/11/2006 and has its registered office in the State of Telangana, India. Company's Corporate Identification Number(CIN) is L85110TG2006PLC051845 and registration number is 051845. Currently Company is involved in the business activities of Retail sale of pharmaceuticals, medical and orthopaedic goods and toilet articles. Company's Total Operating Revenue is Rs. 713.10 Cr. and Equity Capital is Rs. 23.94 Cr. for the Year ended 31/03/2025.
The share price of any company is dynamic and keeps changing depending on the trade initiated. The shares have a fixed opening rate and closing rate. The share price for Medplus Health Services is ₹840.75 as on Sep 12, 2025.
The Medplus Health Services is operating in the Pharmaceuticals and health care Sector. It is classified as a Smallcap stock on the BSE.
The market cap of Medplus Health Services is ₹10,074.08 Cr as on Sep 12, 2025.
Today’s highest and lowest price of Medplus Health Services are ₹840.75 and ₹829.25.
The 52-week high/low is the highest and lowest price at which Medplus Health Services stock has traded in the past 52-week or nearly a year. The 52-week high of Medplus Health Services is ₹1,052.05 and 52-week low of Medplus Health Services is ₹603.00 as on Sep 12, 2025.
The Medplus Health Services has shown returns of 1.28% over the past day, 3.07% for the past month, -5.34% over 3 months, 18.36% over 1 year, 5.26% across 3 years, and -5.59% over 5 years.
P/E ratio of and PB ratio of Medplus Health Services are 56.50 and 6.16 on Sep 12, 2025. While the company gives a dividend yield of 0.00 per annum.